Clinical Trials Directory

Trials / Unknown

UnknownNCT02815553

Cardiac Tumors Interventional (Radio Frequency/Laser Ablation)Therapy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
12 Years
Healthy volunteers
Not accepted

Summary

Currently, surgical removal remains the main clinical treatment for cardiac tumor patients. However, part of tumors are hard to completely resect. Also, as thoracoscopic surgeries induce great operation trauma, some patients cannot tolerate or do not will to take the operation. Therefore, new methods and techniques are in urgent need. Our center have a 12-year experience of intervention treatment for solid tumors and has conducted several animal experiments to verify the effectiveness of transthoracic puncture ablation and radiofrequency ablation for ventricular muscle. The purpose of this study is to conduct new method of direct transthoracic cardiac tumor-targeted Radiofrequency Ablation (RFA) or Laser induced Interstitial Thermotherapy (LITT), make minimally invasive treatment plans for cardiac tumor patients, and verify the safety and validity of intervention treatment in long term.

Conditions

Interventions

TypeNameDescription
PROCEDUREDirect Transthoracic Cardiac Tumor Radio Frequency Ablation Therapy
PROCEDUREDirect Transthoracic Cardiac Tumor Laser Ablation Therapy

Timeline

Start date
2016-04-01
Primary completion
2022-08-01
Completion
2022-08-01
First posted
2016-06-28
Last updated
2022-08-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02815553. Inclusion in this directory is not an endorsement.